Arcellx, Inc. (ACLX)
NASDAQ: ACLX · Real-Time Price · USD
115.07
0.00 (0.00%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Arcellx Market Cap
Arcellx has a market cap or net worth of $6.75 billion as of April 28, 2026. Its market cap has increased by 116.87% in one year.
Market Cap
6.75B
Enterprise Value
6.28B
1-Year Change
116.87%
Ranking
Category
Stock Price
$115.07
Market Cap Chart
Since the IPO on February 4, 2022, Arcellx's market cap has increased from $503.15M to $6.75B, an increase of 1,241.83%. That is a compound annual growth rate of 84.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 6.75B | 79.08% |
| Dec 31, 2025 | 3.77B | -9.09% |
| Dec 31, 2024 | 4.15B | 43.89% |
| Dec 29, 2023 | 2.88B | 112.13% |
| Dec 30, 2022 | 1.36B | 170.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Halozyme Therapeutics | 7.74B |
| ImmunityBio | 7.68B |
| Kymera Therapeutics | 6.93B |
| Erasca | 6.68B |
| Protagonist Therapeutics | 6.38B |
| Belite Bio | 6.34B |
| Apogee Therapeutics | 6.32B |
| Terns Pharmaceuticals | 6.11B |